# Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer

> **NCT02937402** · NA · TERMINATED · sponsor: **Vanderbilt-Ingram Cancer Center** · enrollment: 9 (actual)

## Conditions studied

- Non-Small Cell Lung Carcinoma
- Small Cell Lung Carcinoma

## Interventions

- **PROCEDURE:** Bronchoscopy with Bronchoalveolar Lavage
- **OTHER:** Laboratory Biomarker Analysis

## Key facts

- **NCT ID:** NCT02937402
- **Lead sponsor:** Vanderbilt-Ingram Cancer Center
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2018-04-05
- **Primary completion:** 2019-07-08
- **Final completion:** 2019-08-20
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Slow accrual
- **Last updated:** 2019-09-10

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02937402

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02937402, "Bronchoscopy With Bronchoalveolar Lavage in Identifying Biomarkers of Response to Immune Checkpoint Inhibitors in Patients With Non-small Cell or Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02937402. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*